| SWK |
Report |
Adjusted EPS |
BEAT |
pred ~$1.28 vs. cons $1.24 |
MEDIUM |
| SWK |
Report |
Organic sales growth |
IN-LINE |
pred ~+2.0% vs. cons +2.0% |
MEDIUM |
| SWK |
Report |
Adjusted gross margin |
MISS |
pred ~30.1% vs. cons 30.5% |
MEDIUM |
| SWK |
Guide |
FY2026 adjusted EPS midpoint |
UNCHANGED |
guide ~$5.30 vs. cons $5.31 (FY2026) |
MEDIUM |
| SWK |
Guide |
FY2026 adjusted gross-margin expansion |
UNCHANGED |
guide ~+150 bps vs. cons +150 bps (FY2026) |
MEDIUM |
| SWK |
Guide |
FY2026 free-cash-flow midpoint, excluding CAM taxes and fees |
UNCHANGED |
guide ~$800M vs. cons $805M (FY2026) |
LOW |
| SWK |
Guide |
4Q26 adjusted gross-margin target |
UNCHANGED |
guide ~35.0% vs. cons 35.0% (4Q2026) |
MEDIUM |
| SWK |
Return |
Day-1 residual (stock − beta × S&P 500) |
-5.5% |
— |
MEDIUM |
| SWK |
Return |
5-day cumulative residual |
-7.0% (FOLLOW-THROUGH) |
EPS is likely helped by below-the-line interest savings, while an adjusted-GM print of ~30.1% versus ~30.5% consensus questions the required margin cadence. Reaffirming a ~$5.30 FY2026 EPS midpoint versus ~$5.31 consensus leaves the second-half burden intact, so out-period estimates and the 4Q26 35.0% margin target remain vulnerable to downward revisions. |
MEDIUM |